Premier Path Wealth Partners, LLC Arbutus Biopharma Corp Transaction History
Premier Path Wealth Partners, LLC
- $634 Billion
- Q3 2024
A detailed history of Premier Path Wealth Partners, LLC transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Premier Path Wealth Partners, LLC holds 40,000 shares of ABUS stock, worth $128,000. This represents 0.02% of its overall portfolio holdings.
Number of Shares
40,000
Previous 36,000
11.11%
Holding current value
$128,000
Previous $111 Million
38.44%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding ABUS
# of Institutions
155Shares Held
99.5MCall Options Held
2.31MPut Options Held
525K-
Morgan Stanley New York, NY21.7MShares$69.5 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY12.9MShares$41.2 Million26.34% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$37 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.92MShares$28.5 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.39MShares$26.8 Million10.86% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $480M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...